Javascript must be enabled to continue!
Fluid restriction in patients with pulmonary arterial hypertension and right heart failure
View through CrossRef
Background: In pulmonary arterial hypertension (PAH) right heart (RH) failure is associated with high mortality and poor prognosis. The objective of this cohort study was to assess, whether reduction of fluid-intake is associated with RH size and clinical outcome in PAH patients.
Methods: A retrospective, exploratory analysis of patients with invasively diagnosed PAH and signs of fluid retention who were routinely clinically monitored for 8.4±5.3 months including fluid-uptake and signs of RH failure was performed. Patients were advised to reduce fluid-uptake to a maximum of 2 litres per day (l/d) according to clinical routine. Clinical characteristics of patients with normal fluid-intake <2l/d vs. high fluid-intake ≥2l/d and patients who reduced vs. patients with increased fluid-intake during follow-up were compared. Furthermore, the influence of hospitalization due to fluid overload and for treatment with iv diuretics at baseline and fluid-intake on survival and time to clinical worsening (TTCW) were investigated.
Results: Out of 66 patients with signs of fluid retention at baseline (normal fluid-intake <2l/day, n=16; high fluid-intake ≥2l/d, n=50), 21 presented with hospitalization due to fluid overload, which was significantly associated with worse survival (p=0.004) and TTCW (p<0.001). During follow-up patients who reduced fluid-intake <2l/day presented with in trend reduced right ventricular area (p=0.051) and longer TTCW (p=0.007). Hospitalisation due to fluid-overload and fluid-intake during follow-up were independent predictors of TTCW.
Conclusions: Restriction of fluid-intake in PAH patients was highly effective and associated with significantly longer TTCW. Further evaluation of fluid restriction in PAH patients is needed in larger studies.
Title: Fluid restriction in patients with pulmonary arterial hypertension and right heart failure
Description:
Background: In pulmonary arterial hypertension (PAH) right heart (RH) failure is associated with high mortality and poor prognosis.
The objective of this cohort study was to assess, whether reduction of fluid-intake is associated with RH size and clinical outcome in PAH patients.
Methods: A retrospective, exploratory analysis of patients with invasively diagnosed PAH and signs of fluid retention who were routinely clinically monitored for 8.
4±5.
3 months including fluid-uptake and signs of RH failure was performed.
Patients were advised to reduce fluid-uptake to a maximum of 2 litres per day (l/d) according to clinical routine.
Clinical characteristics of patients with normal fluid-intake <2l/d vs.
high fluid-intake ≥2l/d and patients who reduced vs.
patients with increased fluid-intake during follow-up were compared.
Furthermore, the influence of hospitalization due to fluid overload and for treatment with iv diuretics at baseline and fluid-intake on survival and time to clinical worsening (TTCW) were investigated.
Results: Out of 66 patients with signs of fluid retention at baseline (normal fluid-intake <2l/day, n=16; high fluid-intake ≥2l/d, n=50), 21 presented with hospitalization due to fluid overload, which was significantly associated with worse survival (p=0.
004) and TTCW (p<0.
001).
During follow-up patients who reduced fluid-intake <2l/day presented with in trend reduced right ventricular area (p=0.
051) and longer TTCW (p=0.
007).
Hospitalisation due to fluid-overload and fluid-intake during follow-up were independent predictors of TTCW.
Conclusions: Restriction of fluid-intake in PAH patients was highly effective and associated with significantly longer TTCW.
Further evaluation of fluid restriction in PAH patients is needed in larger studies.
Related Results
Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects.
Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects.
In patients with pulmonary hypertension associated with congenital heart defects, ultrastructural abnormalities are observed in endothelial cells, which suggest heightened metaboli...
Pulmonary hypertension associated with left-sided heart disease
Pulmonary hypertension associated with left-sided heart disease
Pulmonary hypertension associated with left-sided heart disease (PH-LHD) is the most common type of pulmonary hypertension. In patients with left-sided heart disease, the presence ...
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Background: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are chronic diseases with a severe symptom burden. Common symptoms are dyspnoea at lig...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
Principles of pharmacological correction of pulmonary arterial hypertension
Principles of pharmacological correction of pulmonary arterial hypertension
Definition and classification: Pulmonary hypertension (PH) is a group of life-threatening progressive diseases of various genesis, characterized by a progressive increase in arteri...
Assesment of factors for late diagnosis of idiopathic pulmonary arterial hypertension in real clinical practice
Assesment of factors for late diagnosis of idiopathic pulmonary arterial hypertension in real clinical practice
Idiopathic (primary) pulmonary arterial hypertension – a rare progressive disease that shortens life, usually diagnosed at a late stage. Therefore, it is critical to have a low thr...
Evaluation of pulmonary hypertension and its relationship with serum parathyroid hormone levels in hemodialysis patients
Evaluation of pulmonary hypertension and its relationship with serum parathyroid hormone levels in hemodialysis patients
Introduction: Pulmonary hypertension is a progressive and severe disease associated with left or right ventricular dysfunction and is common in patients under hemodialysis. One of ...
Assessing survival time of heart failure patients: using Bayesian approach
Assessing survival time of heart failure patients: using Bayesian approach
AbstractHeart failure is a failure of the heart to pump blood with normal efficiency and a globally growing public health issue with a high death rate all over the world, including...


